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Precision medicine and molecular systems medicine (MSM) are highly utilized and
successful approaches to improve understanding, diagnosis, and treatment of many
diseases from bench-to-bedside. Especially in the COVID-19 pandemic, molecular
techniques and biotechnological innovation have proven to be of utmost importance
for rapid developments in disease diagnostics and treatment, including DNA and
RNA sequencing technology, treatment with drugs and natural products and vaccine
development. The COVID-19 crisis, however, has also demonstrated the need for
systemic thinking and transdisciplinarity and the limits of MSM: the neglect of the
bio-psycho-social systemic nature of humans and their context as the object of
individual therapeutic and population-oriented interventions. COVID-19 illustrates how
a medical problem requires a transdisciplinary approach in epidemiology, pathology,
internal medicine, public health, environmental medicine, and socio-economic modeling.
Regarding the need for conceptual integration of these different kinds of knowledge
we suggest the application of general system theory (GST). This approach endorses
an organism-centered view on health and disease, which according to Ludwig von
Bertalanffy who was the founder of GST, we call Organismal Systems Medicine (OSM).
We argue that systems science offers wider applications in the field of pathology
and can contribute to an integrative systems medicine by (i) integration of evidence
across functional and structural differentially scaled subsystems, (ii) conceptualization of
complex multilevel systems, and (iii) suggesting mechanisms and non-linear relationships
underlying the observed phenomena. We underline these points with a proposal
on multi-level systems pathology including neurophysiology, endocrinology, immune
system, genetics, and general metabolism. An integration of these areas is necessary to
understand excess mortality rates and polypharmacological treatments. In the pandemic
era this multi-level systems pathology is most important to assess potential vaccines,
their effectiveness, short-, and long-time adverse effects. We further argue that these
conceptual frameworks are not only valid in the COVID-19 era but also important to be
integrated in a medicinal curriculum.
Keywords: Organismal Systems Medicine, systems theory, dynamic equilibrium, polypharmacology, multi organ
disease, excess mortality rate, multi-level view model
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THE COMPLEXITY OF COVID-19 QUESTS
FOR AN INTEGRATIVE FRAMEWORK WITH
A FOCUS ON A BIO-PSYCHO-SOCIAL
MODEL
Molecular systems medicine and computational medicine were
helpful for the understanding and management of COVID-19
pandemic. Moreover, the importance of mathematical modeling
in epidemiology demonstrates the benefits of generic system
models that can be used to compare causally different cases (such
as the Spanish flu, Ebola and Covid-19) and are also necessary
to lead political decisions (1, 2). The societal importance of
integrated medical knowledge has become particularly obvious
during the COVID-19 pandemic. The understanding and
management of COVID-19 pandemic exposes the dissociation of
specialized diversity of medicine such as virology, epidemiology,
public health, internal medicine, etc. Molecular analysis of
mechanisms of infection, epidemiological data on spreading and
their mathematical extrapolation alone are insufficient to foresee
and avoid catastrophic developments. This exemplifies that
empirical research on Covid-19 necessitates analysis of systemic
feedback and feedforward mechanisms as well as collateral effects
on all levels of organismic organization, on the “ecology of
the person” (3) and on the level of institutional management
of the pandemic. For example, for differential understanding
of the high rate of case fatalities on the population level
clinical knowledge of individual courses of the disease must be
integrated with views of basic research in various disciplines
not only of immunology, but also endocrinology and even
neurobiology. Regarding adherence to prevention regulations,
psychology of distancing, and social sciences of lock downs must
be considered in order to depict the real-life situation of people
(3, 4). Higher mortality rates among some population groups
cannot be understood through molecular, or even “biological”
factors alone, but also involves consideration of psycho-social
conditions of life, socioeconomic disparities, and sociocultural
orientations; COVID-19 is a syndemic (5). An integration of all
these factors into a comprehensive conceptual framework for
COVID-19 is proposed in Figure 1. A general system-theoretical
bio-psycho-social model for medicine and the education of
health professionals has been suggested already in the 1970 by
George Engel (9). Regarding this (nearly forgotten) integrative
and multidimensional model a bio-psycho-social pathology on
individual and population level could improve understanding
varieties, for example in clinical Covid-19 courses and also could
have practical effects in management of the pandemic. But it
also would enable a wider understanding of societal conflicts
between restrictive hygiene suggestions, rights for freedom, and
impaired economic vitality (see Figure 1). These conflicts exert
a strong disturbance on everyday life organization and need
a comparative and sophisticated discussion. Smart health care
delivery can lower thresholds for access and improve acceptance
of the targeted population. In case of in-patient treatment units
also a human-centered management structure and style, e.g.,
“systemic management concepts,” could prevent burn-out of the
staff and could enhance success of public health goals (6, 7, 10).
Later on, we sketch those issues focusing on somatic processes
but being aware of environmental factors as contexts. In the
context of human sciences the term “environment” has two
epistemicmeanings: “subjective” environment according to Jacob
von Uexküll (11), and “objective” environment in the sense of
Ernst Haeckel (12). This difference corresponds to the clinical
data, e.g., if someone is clinically obese and subjectively not
aware of it. Integration of data across such different domains
is a key task which is exactly the domain of system theory that
aims to transform bio-psycho-social data sets to a framework of
a functional language that represents an ontology of functions
as well as their quantification as discussed later. Furthermore,
the need for the conceptual integration of different organismal
subsystems to understand the mechanisms of the pandemic
raises basic questions about the epistemic power of contemporary
systemsmedicine, which is discussed below. Regarding themulti-
organ manifestation of COVID-19, a co-evolution of new disease
ontologies, data integration and interoperability strategies that
use omics-based classifications and combine them with clinical
ontologies are highly fruitful (13).
FROM MOLECULAR TO ORGANISMAL
SYSTEMS MEDICINE
Medicine today relies on three major pillars: (i) clinical
knowledge and practical experience, (ii) classical diagnostics
and evidence-based treatment on the basis of expected value
decision making and (iii) multiomics combined with advanced
statistical/mathematical analysis such as machine learning and
mathematical modeling. Here, precision medicine and molecular
systems medicine (MSM) are highly utilized and successful
approaches to improve understanding, diagnosis and treatment
of many diseases, based on data from multiomics technologies,
data statistics and modeling (14–21). Genome-wide-association
studies (GWAS) of COVID-19 are rather at the beginning
but are highly promising to reveal critical illness cases (22,
23). For data gathering, diagnostics and prediction models
machine and deep learning techniques and applications of
artificial intelligence are of utmost importance but also need
to be critically reviewed (24–29). Altogether, there is a risk
that classical medical knowledge, especially qualitative, and
intuitive knowledge of organismic pathology, will be lost before
the transition to MSM can be implemented clinically. Also,
these technologies neglect the bio-psycho-social dimension of
medicine as discussed above (4). Interestingly, the technology-
and data-driven epistemology of MSM is not yet sufficiently
understood regarding the gap between correlation and causation
[(30); Table 1 and discussion below], especially comparing it
with the very special bedside-epistemology of physician-based
and patient-based observations and experiences of health and
disease. The combination of implicit biochemical reductionism
of physiology and data-reductionism of health phenomena
implicates the lack of conceptual inter-level and interdisciplinary
integration, namely the neglect of the epistemic weight of
clinical experience that is concerned with the whole person.
Current documentation within electronic health records (EHRs)
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FIGURE 1 | Systemic compartment model of the individual person with its respiratory system that primarily is confronted with and affected by SARS-CoV-2, that
invades cells within tissues of respiratory (and others) organs of the organism, step by step. But invasion can be attenuated by local defense mechanisms (circular
lines with transoms). Spreading of the virus can occur (stippled arrow). The person can experience the sickness by symptoms (stippled double arrow) and/or obtains
and utilizes the information provided by the respective socio-economic system on micro-, meso-, and macro-level and its knowledge about the virus and its
prevention and treatment. With this mindset, depending on social context, the person might change behavior by reduction of the exposure (–) by lockdown,
distancing, quarantine etc. or will exert risky behavior (+) with respective consequences for the social environment. A major feedback loop is also organization of
health care and other services (6, 7) as well as access to these health care services which is not equally distributed in the society (5, 8).
is not designed to treat the patient as an organism, but rather
as a suite of documentation regarding the clinical encounter
and for billing purposes (13). We can learn a lot from the
rare disease community (among others) where there is a need
to support multi-species and multi-modal data integration
to inform diagnostics and treatment discovery. Most of this
documentation regarding the patient happens outside the EHRs
in order to support the observations of the patient as an
organism (13). We have not well-applied this approach to
COVID patients yet. In consequence, not only a unidirectional
but rather a bidirectional relation between bench and bed
(physician and patient) could improve efficacy of translational
medicine. This could be “vertical transdisciplinarity” that
complements “horizontal transdisciplinarity” as conventional
interdisciplinarity and that combines scientific knowledge
production with physicians and patients observations and
experiences (49–52).
In consequence, we take a conceptual and theoretical
approach that is organism-centered conceiving the organism as
system of organs, tissues, and cells and that also envisions the
organism as a living system-in-the-world. We appeal to the need
for an “Organismal Systems Medicine” (OSM) in the sense of
Bertalanffy (53, 54) to complement MSM by accounting for the
systemic and ecological context of the organism.
This approach can be seen as a complementary procedure
to the bottom-up methodology of current MSM as it is an
organism-centered (or: person-centered) top-down functional
analysis. This holistic starting point of biomedical research is
aware of contextual factors such a psycho-social factors that
come up as risk factors and/ or protective factors for health and
disease. One of the central concepts of OSM is the adaptive, self-
organized dynamic equilibrium (“flow equilibrium”) of partially
antagonistically operating components of the system. Dynamic
equilibrium is constituted by the assumption of hierarchical
partial antagonisms and synergisms between activators and
inhibitors that converge on operators of different organizational
levels of complex organisms (organs, tissue, cells, andmolecules).
This is a heuristically fruitful concept to organize observed
phenomena and data and it is also a guiding principle for
organizing experimental and field research as we will show later.
EPISTEMOLOGY OF MOLECULAR AND
ORGANISMAL SYSTEMS MEDICINE
Altogether, a differentiated but integrated systemic methodology
could improve our understanding and managing of COVID-19
but also future challenges. Accordingly, it has to be considered
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TABLE 1 | Epistemological desiderata of systems thinking in biology.
Problem Literature
Bilateral relations between data and theory, difficulties of
causal inference based on correlations
(31, 32)
Reduction and holism, whole–parts relations: can the
knowledge of molecular biology explain higher functions
of the whole organism?
(33)
Limits of bottom-up explanations of social phenomena
by molecular biology
(34)
Systemic multilevel ontologies and emergence (35)
Chance and necessity: Is there a significant difference
between randomness and determinism?
(36)
Examples of top-down causation (37)
Epistemology of computational modeling (38)




The structure of explanations and theories in biology (43)
The ontology of life (44)
The limited explanatory power of evolutionary theory (45, 46)
The concept of goal-directedness as teleonomic but not
teleological property of living systems
(47)
The relevance of the concept of self-organization (48)
These topics are dealing with conceptual problems that underly the need for
systems medicine.
that epistemic limitations of valuable MSM show up focally,
but they are not worked out in a broader way. In contrast,
systems biologists and philosophers alluded to methodological
difficulties/limitations of claims of early systems biology (55, 56).
Some examples for important metatheoretical topics that would
frame methodology of systems medicine are listed here [(30);
see Table 1]: The part-whole problem, bottom-up vs. top-down
causation, mechanistic vs. nomological explanations, complexity
reduction, epistemics of interdisciplinarity, determinism and
self-organization, correlation and causation, emergence vs.
reductionism, robustness vs. homeostasis. Several of these
problems are relevant for a holistic MSM (57). Selected aspects
are discussed in the following.
Functional Organization of the Organism
A major challenge in biomedical research is to understand
the functional organization of a living system across multiple
levels. Several taxonomies were presented in history of systems
science that intend to capture conceptually a limited set of
“essential functions” like respiration, circulation, reproduction,
or more general like adaptation, assimilation, integration,
differentiation, etc. (58). Biological functions (e.g., defense
functions such as inflammation) can be localized at different
levels of organization (e.g., molecules, cells, tissue, organs), using
different methodologies. Biases sometimes occur as a result
of downgrading factors that are left out of the analysis when
focus is directed at a specific functional level. This type of bias
was called by the philosopher William Wimsatt as functional
localization fallacies (59). For example, research in recent decades
has focused on the impact of specific genetic mutations on
cancer development and treatment response. While successful,
this approach has also created blind spots, since environmental
and biomechanical factors at higher scales are often ignored or
held fixed as a methodological necessity. Genetics can infer a
correlation of cancer treatment and treatment success. But this
phenomenological association cannot be explained by genomics
alone, as success of cancer treatment is also impacted by other
systems such as the immune and endocrine system. Thus, the
analysis of the cancer alone is insufficient, as it neglects the impact
of the treatment on other parts of the organism.
Level of Conceptual Resolution
It is often assumed that the precision of models increases as
more details are incorporated, and some have even argued that
the principle of Occam’s razor does not apply to biology in
the computational age (60). Inclusion of ever more molecular
details could impede the predictive capacity of models, especially
if these are not contextualized within the overall system
organization: Living systems exhibit what Mihajlo Mesarovic
termed bounded autonomy of levels (61). Cross-level relations
in biology are neither independent nor linearly coupled—rather,
they are dynamically autonomous within certain boundaries.
Examples are how phenotypic states are often resilient to genetic
mutations or changes in expression levels. As living systems
are not homogenously organized, upscaling of models is not
accomplished by simple averaging of lower-scale details. In
contrast, multi-scale modeling of living systems requires an
understanding of how the system is hierarchically organized,
and how higher-scale structures can exert top-down control over
lower scales through constraining relations (62). An example
which is more elaborated below is stress-dependent release of
cortisol with downstream effects on organ-level (63).
Top-Down Causation
The relevance of top-down influences is exemplified by recent
insights from multi-scale modeling of the human heart and
the cardiovascular system (41), embryonic development (64),
fracture risk in bone (42), organogenesis, and cancer (65, 66). In
these contexts, macro- and meso-scale models represent higher-
level features that act as boundary conditions for models at
lower scales (67). Top-down causation occurs when higher-level
structures shape lower-level interactions and channel dynamic
possibilities, some of which would be impossible to reach for
an unconstrained system (62). Just like the heart rhythm is
possible due to constraints of the cell membrane and higher-
level structures (37), the wiring of biological networks constrains
lower-levels states and give rise to generic functions such as
feedback control or signal implication. System theory can help
to identify similarities in the patterns of organization in different
systems, and hence to recontextualize the inputs from data-
intensive fields (40).
ORGANISMAL SYSTEMS MEDICINE AS AN
INTEGRATIVE FRAMEWORK
As alreadymentioned briefly, some of these theoretical challenges
for systemic thinking were already tackled by the philosopher
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and biologist Ludwig von Bertalanffy who made significant
contributions to the field through his formulation of General
System Theory (54). This theory should enable researchers from
different disciplines to conceive their epistemic object as a
dynamic system. Although his conception was already grounded
on early biochemistry, molecular biology, and mathematics,
he proposed an organism-centered view (organismic systems
biology) (53). He underlined this idea by defining a system as a
“structured whole.” In addition, the perspective of developmental
biology was crucial for his concept of a theoretical function-
oriented biology.
Concepts and Models
Ludwig von Bertalanffy, Mihajlo Mesarovic, and other founders
of systems biology, like James G. Miller, proposed explicit
conceptual multi-level models to describe, explain, and predict
dynamics of states of living systems. These ideas had also
interdisciplinary relevance as GST was also developed in context
of sociology by Talcott Parsons who designed a heuristic
scheme that assumes that social systems have to fulfill four
basic functions: adaptation, goal attainment, latent pattern
maintenance, and integration (68). In consequence, these
concepts could probably be useful for a general functional
understanding of the organism and its pathology.
One of the most significant basic and already elaborated
concepts is the notion of “dynamic equilibrium” (German notion:
Fliessgleichgewicht) that governs processes on different levels
of the organism. It is constituted by asymmetric antagonistic
convergence operations of systemic cellular and molecular
components, e.g., the nervous system (“autonomic network”
of ergotropic sympathetic vs. trophotropic parasympathetic
autonomous nervous system) (69), endocrine system (blood
glucose regulation by antagonistic hormones) and immune
system (pro- vs. anti-inflammatory agents). The action of
these subsystems converge overlapping on sites of homeostasis
of organ functions such as cerebral stress reactions, glucose
homeostasis or balanced defense reaction. This concept of a
dynamic interplay between accelerators and brakes can be a
guiding principle not only to describe, but also to explain and
understand temporal patterns of organismic processes in health
and disease.
Systemic Methods
During the last decades, several methods of systemic modeling
were developed from qualitative models in context of systems
dynamics, via mathematical models, computerized modeling
tools, and data-driven inverse modeling (32). Aiming to
construct comprehensive models with high ecological validity,
transdisciplinary approaches that connect practitioners and
researchers from various fields of relevance are the basis
of successful modeling as it was elaborated in sustainability
science (70, 71). Qualitative conceptual models are developed,
formulated by simple verbal, graphical and tabulation tools
(Figure 2). In a next step, the model will be transposed
into a data-based mathematical formulation that can be used
for exploratory computer simulations that need not much
mathematical literacy such as programs Stella or Vensim (55).
Notably, in this procedure the conceptualization of a system
model can easily be done by graphical tools that facilitate
interdisciplinary communication (Figures 2, 3). Already simple
graphs of process structures, such as feedback and feedforward
loops, can capture features of systems dynamics. Complex
structures of process conditions (e.g., biochemical pathways) can
be studied in this view qualitatively by identification of generic
dynamic principles or “motifs” (72). This type of modeling
is a classical forward approach, however, inverse or reverse
approaches feeding data directly into model building are even
more promising (19, 32). Data driven medical diagnostics and
anamnesis are inverse problems per se. A classic example
of biomedical inverse problems are imaging techniques from
tomography to microscopy. Relating the acquired data to the
unknown object is an inverse problem and requires mathematical
modeling (73).
SYSTEMS PATHOLOGY
Pathology is a key discipline inmedicine and nowadays its subject
is split into subsystems (organs and tissues) which are well-
understood on the anatomical, physiological, cellular, molecular,
and biochemical level. In line with our proposition for the utility
of a function-oriented structural analysis, physiology, anatomy,
and histology are central to make sense of the richness of these
molecular data. Morphological macro- and micro-structures
provide the boundaries and connecting structures that enable
functions such as metabolism, respiration, circulation etc. The
central challenge is to develop an integrative multi-level “systems
pathology” that connects classical physiological and clinical
knowledge with current rich molecular biological knowledge.
The linkage between molecular and cellular models (bottom
up) and the organ and organism level (top down) as in top-
down causation models is a rather underrepresented approach
(Figure 3). This step requires systematic methods of vertical
integration of model inputs, translating from themolecular to the
whole-system level and vice versa. One elaborated and validated
example is the integrative multi-level model of the heart activity
covering molecular and cellular mechanisms (75) and also a
multi-organ model of the thyroid control loops (76). Regarding
COVID-19 only a few attempts were made to design a multi-
stage systems view on the pathology of this disease (77, 78). Such
models should be constructed basically as multi-level models that
integrate organismal physiology with molecular studies. Methods
of sensitivity analysis can be used in order to study the effects of
molecular properties and events (e.g., enzyme kinetics, receptor
binding and certain genetic variants) on the behavior of the
whole system from cells, tissue, and organs up to the level of
the organism. Conversely, “reverse sensitivity analysis” allows
for concluding from the behavior on the organismic tier to an
affine subspace of sensible parameter values on the molecular
level (Figure 3).
Preconditions for this advanced modeling technique include
certain measures on both the systems and the molecular
levels. On the higher level, it is required that the network
structure follows a “parametrically isomorphic” paradigm, i.e.,
that the model is constructed from building bricks that can be
mapped to knowledge from molecular research in a bijective
manner. On the other hand, research on the lower level has
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FIGURE 2 | Methodology for iterative optimization of exploratory and quantitative models in Systems Medicine. In the following the workflow is described: (i) data
collection, observations in a “transdisciplinary” groups, (ii) generation of data matrices, (iii) drafting a verbal model of interactions of components, definition of the
system, elements, relations, and boundaries necessary for the subsequent formal models (iv) construct graphical model of causal loops and/or of stocks and
flows/effects (decide about graphical language), (v) drafting mathematical equations, (vi) parameter estimation and fitting using existing data, state and flow variables,
and coefficients (if not possible: “educated guess” by expert-based estimations), (vii) transposition to computational model simulation, model tests, validation,
scenarios: “…if, then…,” (viii) model prediction and extrapolation and comparison with data, further validation and model optimization with backward improvements
(for further details see text).
to deliver quantitative results providing meaningful information
on stimulus-reaction relations, temporal dynamics etc., and
thereby enabling parameterization of the high-level models
(Figure 3). Reusable libraries of universal motifs and building
bricks (e.g., feedback loops, feedforward motifs, antagonistic,






Even on a semi-quantitative level, systemic modeling is
heuristically relevant. Regardless of the details available on
subtypes of cells, receptors, signaling molecules etc., there is
lot of evidence of the antagonistic organization and regulation
of an integrative neurophysiological, endocrine, and immune
system. The integration of these subsystems has implications
for neurophysiological complications, excess mortality rates,
and polypharmacological treatment for COVID-19 (77, 82–84)
but also the assessment of potential novel vaccines such as
the mRNA vaccines and their short- and long-term adverse
effects due to mass vaccination, e.g., autoimmune reactions and
neurophysiological manifestations (82, 85–88). The interaction
of the neurophysiological, endocrine, and immune system is
discussed in the following.
The Neurochemical Antagonism
Most clinical observations in neurology and psychiatry confirm
the view that a delicate dynamic equilibrium exists between
activating and inhibiting neurotransmitter systems, although
anatomic and pharmacological details (e.g., receptor subtypes)
are more complicated (55): activating (ergotropic) noradrenaline
(NA) and inhibiting (trophotropic) acetylcholine (ACh) oppose
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FIGURE 3 | Today’s biomedical research is faced by the challenge that descriptions of the systems of interest are restricted to different sublevels. A high-level theory
covers a systems view, addressing large subsystems, e.g., multi-organ feedback control systems or even the whole organism including psychosocial relations. This is
complemented by a low-level description of molecular structure and reactions. Unfortunately, the vertical translation, e.g., how molecular data are integrated into the
high-level system description, is difficult. Methods of vertical integration include affine subspace mapping (top-down inference), sensitivity analysis (bottom-up
reasoning) and graphical tools. They require, however, certain preparative steps on both tiers of research to be feasible (74).
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partially to each other, with different patterns of dynamics.
They represent a body-wide antagonistic regulation of functions
(heart, blood vessels, lungs, pancreas, gut system, etc.). On
a second operational level, synergistically connected with
NA, the neurotransmitter dopamine (DA), and serotonin (5
hydrotryptamine, 5-HT) exhibit a partial antagonism. On the
side of ACh, fast operating excitatory glutamate (Glu) and
inhibiting GABA show also partial antagonism. Clinically, these
interactions can be seen in disorders like Parkinson’s disease
with a dominance of acetylcholine over dopamine because of
loss of dopamine cells: substitution of dopamine can induce
a psychotic syndrome and in turn neuroleptic treatment of
psychoses can evoke a Parkinson’s syndrome. By integrating such
antagonistic effects into a neurochemical network model that can
be simplified as a “neurochemical mobile,” the neurochemical
basis of several neuropsychiatric syndromes can be described,
and explained even quantitatively by computer simulations
(89, 90). Effects of new medications (glutamate antagonists)
can be predicted as well (anti-depressive effects): in depression
NA, DA, and 5HT exert a hypofunction in neurotransmission,
compared to a hyperfunction of ACh, Glu, and GABA. In
consequence, selective serotonin reuptake inhibitors (SSRIs) that
enhance 5HT transmission work as antidepressants and also
glutamate antagonists such as ketamine can reduce depressive
syndromes (91). Interestingly, all these neurotransmitters operate
on probably all organismic cells and many body cells even
produce transmitters (e.g., immune system).
The Endocrine System
The endocrine system is a multi-organ system partially centered
around the pituitary gland (92). The principle of asymmetric
antagonistic convergence is only weakly confirmed in the
endocrine system, but at the peripheral organ level the interplay
of glucagon and insulin confirm this concept. The most
important hormone is cortisol, a steroid hormone produced in
the adrenal glands. It involves a range of processes related to
metabolism, stress and immune response. It works ergotropic
and is partially synergistically to NA and classic thyroid
hormones. The main feature of the cortisol system is its multi-
level upstream connection with the CNS via hypothalamus
and the pituitary gland. This connectivity is often quoted
as hypothalamus-pituitary-adrenal or HPA axis: HPA axis
elevates cortisol level which in turn inhibits the HPA axis via
glucocorticoid receptors in hypothalamus and pituitary gland as
a feedback inhibition. This feedback loop exhibits several cyber-
systemic features that make several pathologies [e.g., stress; (63)]
understandable: delayed feedback with consecutive oscillations,
delays, adaptation, allostasis etc. characterize the dynamics of
endocrine systems.
Interestingly, the HPA axis has multiple antagonists on
various anatomical levels (each of them antagonizing certain
partial functions) (Figure 4). They include growth hormone
(anabolic action), insulin (glucose-lowering and anabolic
function), hormones of the non-classical renin-angiotensin
system (angiotensin 1-7, angiotensin 1-9, angiotensin A, and
alamandine with hypotensive and hyponatremic actions) and
thyroid hormones (HPT axis, central antagonism). It is therefore
not surprising that the HPA axis is upregulated in critical
infectious diseases, including COVID-19, while the HPT axis is
downregulated (93).
The Immune System
Regarding the principle of antagonistic convergence, the
immune system has a (fast) pro-inflammatory and (slow) anti-
inflammatory functional differentiation, for instance by signaling
via Th1 and Th2 cells (94). Interferon (IFN) and tumor necrotic
factor (TNF) are secreted from Th1 cells that amongst other
effects activate macrophages and inhibit activity of Th2 cells that
in turn can also inhibit Th1 cells by interleukin IL-4, IL-10 etc. In
acute inflammation, Th1 subsystem dominates Th2 subsystem,
in case of chronic inflammation Th2 subsystem dominates Th1
subsystem. In case of COVID-19, pro-inflammatory components
exhibit a persistent overactivation. In response to a local
pathogenic challenge, an innate immune response is initiated
by type I interferons (IFN) and pro-inflammatory cytokines like
tumor necrosis factor alpha (TNFalpha), interleukin 1beta (IL-
1beta), and interleukin-6 (IL-6). Later on, when the adaptive
immune response kicks in, an overreaction of the immune system
is prevented by anti-inflammatory factors like TGF-beta and
interleukin-10, thus, generating a negative feedback loop onto
the immune response. In the case of COVID-19, this latter step
sometimes fails to keep the immune response under control (84).
The Multi-Level/Multi-Function Interaction
The complexity of these and other regulatory systems can
be structured conceptually by a multi-level/multi-function
interaction network. Regarding the immune system, it is well-
known that ACh inhibits macrophages to secret TNF, whereas
NA could stimulate TNF secretion via alpha- and beta-receptors
(95). In synergy with ACh, cortisol also suppresses macrophage
activity. Several other examples can be worked out (96),
e.g., multimorbitidy and the problem of polypharmacy that
affects about 20% of the population (97, 98). For instance,
the comorbidity of diabetes mellitus and depression can be
revisited by looking to molecular signaling cross-overs between
the CNS (relative hypofunction of noradrenaline, dopamine and
serotonin compared to acetylcholine, glutamate, and GABA in
depression) and the physiological control of beta and alpha cells
in pancreas physiology by these neurotransmitters and also the
effects of insulin in the brain, etc. (99). In addition, imbalances
within the immune system (elevated IL-6) contribute to the
occurrence of depression (e.g., side effect of interferon therapy)
and diabetes.
In consequence, these subsystem interactions need
to be analyzed in detail on the basis of a reference
network model. With regard to COVID-19, chronic
bio-psycho-social stress situation could evoke the
severe persisting shift in the immune system toward
pro-inflammatory mechanisms.
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FIGURE 4 | The hypothalamus-pituitary-adrenal (HPA) axis is the major stress mediator system on an intermediate time scale. It is stimulated by catecholamines
(representing the fast stress system) and inhibited by thyroid hormones (as slow mediators of stress and allostatic load). In addition, it has multiple antagonists
inhibiting partial functions at peripheral levels of the processing structure, some of them (marked by *) resulting from ACE2 activation. AT, angiotensin; STH,
somatotropic hormone. For more details see text.




The utility of systems thinking in medicine, especially in the
case of COVID-19, is obvious in epidemiology by the universal
application of SIR compartment models and their derivatives
which help to understand and explore the dynamics of spreading
of the virus (100). The diverse exposure features (asymptomatic
carriers) are crucial for infection so that models have to be
extended (2). At this population level, data analysis andmodeling
demonstrate the dangerous dynamics of exponential growth.
Several theoretical challenges exist to represent the mechanisms
of focal spreading and for evaluation of measures. They can
only be partially solved by agent-based modeling, but only if the
collateral effects of public health measures (home quarantine,
lockdown) are also included in an ecological perspective of
human beings (Figure 1). Systems theoretical analyses can help
to explore and designmanagement strategies ensuring health and
economy, e.g., by cyclic management of lock down (101).
In addition, we propose an integrative compartment-based
andmulti-layer- and multi-level-oriented systems pathology, as a
systemic understanding of Covid-19. It could help to explain the
causes of asymptomatic clinical courses of SARS-CoV-2 infected
persons. The complex pathophysiology of COVID-19 starts at the
entrance of the virus in the compartment of the upper airways
(nose, throat) with its local defense mechanisms on the layer of
fluids that protect the mucosa (nasal mucus), the local expression
of ACE2 on cells and the local presence of immune cells etc..
In this view, still the trivial pathophysiological question is not
clarified if tonsillectomized individuals are at a higher risk that
infection “jumps” down to the second compartment, the lower
airways, respectively, to the alveola where the fatal mechanisms
of hyper-inflammation occur: there might be a higher risk
for respiratory dysfunction in tonsillectomized persons (102).
Thus, the respiratory system in case of airborne virus invasion
must be explored as a “structured whole” (compartment model),
being connected with the circulatory system via alveoli thus
providing oxygen for the whole organism and emitting carbon
dioxide. In addition, each compartment should be conceived
as being composed by a heterogeneous multi-layer tissue and
should be modeled from tissue to cells to molecular processes of
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FIGURE 5 | Interaction of the HPA axis with the immune system in COVID-19: Antagonistic convergence on ACTH production by inhibitory cortisol feedback and
activating interleukin-6 that is released by macrophages after contact with SARS-Cov-2. The structure of the feedback loop explains the glucocorticoid paradox in
COVID-19, i.e., that elevated serum concentrations of cortisol are associated with poor prognosis but that pharmacological use of glucocorticoids like prednisolone or
dexamethasone leads to improved outcomes. For more details see text.
viral pathology addressed by molecular systems biological tools
(103, 104). Here, one should not look only to effects on and
of the molecular mechanisms of the endocrine system (renin-
angiotensin system vs. cortisol system) in both directions but also
consider the molecular effects on and of the autonomous nervous
system (Figure 5). The crucial clinical problem of Covid-19 is that
it appears as a hyper-inflammatory process as a result of a dynamic
imbalance between pro-inflammatory and anti-inflammatory
components of the immune system: On the immune systems level
a macrophage and Il-6 excess is often reported that seems to lead
to severe courses of Covid-19 (105). Also, a very high cortisol
level is observed at hospital admission that could be functionally
understood as an ineffective counterreaction, maybe because of
down-regulation or desensitization of glucocorticoid receptors
in macrophages (106). However, at first, the cellular invasion
of the virus is based on utilization of the ACE2 receptor with
the consequence that a lower amount of ACE2 is available that
converts angiotensin II to angiotensin 1-7 and angiotensin 1-
5 attaching to the mas receptor and operating antagonistically
to proinflammatory ATR1 (107, 108). In consequence, the anti-
inflammatory effects compared to proinflammatory effects are
persistently lower than under normal conditions. This imbalance
could explain the heavy structural and functional changes in the
alveola. A next step might be the modeling of tissue dynamics
in inflammation that can be explored by computer simulations of
models of cell-cell interactions, namely as it was demonstrated for
macrophages and fibroblasts showing that interaction structures
based on growth factors can reach bistable homeostasis. This
system theoretical concept that assumes a strong attractor
basin in pro-inflammatory state space facilitates to understand
pathological locked-in states of cell systems as they are found in
alveolar pathology in Covid-19. As a starting point for a systemic
view on COVID-19, a simplemodel could integrate the activation
of the HPA axis by the inflammatory response triggered by virus
invasion, where cortisol has again an immunosuppressant effect
(Figure 5). The interaction of the involved three feedback loops
could explain both markedly deranged blood glucose levels in
diabetics infected with the SARS-CoV-2 virus (109), especially in
severe cases (110–112), and the apparent paradox that therapy
with glucocorticoids is able to improve the outcome of COVID-
19 (113), whereas patients with elevated cortisol concentration
face a poor prognosis of the disease (114).
CONCLUDING REMARKS
A system-theoretical framework can provide a more consistent
picture for complex diseases like Covid-19, by bridging the
current gaps in medical knowledge, especially enhancing
clinical knowledge, and experience. Systems theory enables the
integration of multiscale top down (organismal view) and bottom
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up (molecular systems medicine) approaches. We propose the
following unsettled strategies in systems medicine: (i) integration
of biochemically-based and physiology-related dynamic models
considering adaptive dynamic equilibrium, antagonism, and
synergism, (ii) developing models of human and human health
in an socio-ecological context with consequences for health
status, and (iii) extending methodology of systemic modeling,
also qualitative, pre-formal conceptualization techniques for the
implementation of system-theoretical thinking and modeling
technologies in the medical curriculum.
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